Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002274939 | SCV000252770 | benign | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000780224 | SCV000917318 | benign | not specified | 2017-09-19 | criteria provided, single submitter | clinical testing | Variant summary: The EPCAM c.344_345delinsCA (p.Met115Thr) variant causes a missense change involving a codon located in the Thyroglobulin type-1 domain (InterPro). Four in silico tools predicted a benign outcome for this variant. This variant was found in 3/246238 control chromosomes from all ethnicities at a frequency of 0.0000122, which does not exceed the estimated maximal expected allele frequency of a pathogenic EPCAM variant (0.0000284). However, two subpopulations (Latino and South Asian) have frequencies that do exceed this maximum, suggesting the variant may be a benign polymorphism in these populations. In addition, the EPCAM c.344C>T variant (classified as benign in our internal database) causes the same p.Met115Thr change and is reported as the predominant allele in the gnomAD database with a frequency of 0.5225 (144772/277076 chromosomes, 40945 homozygotes), strongly suggesting this is a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Due to the gnomAD frequency for the missense change, which the variant of interest also causes, this variant is classified as benign. |
Ce |
RCV002274939 | SCV002563565 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | EPCAM: BS1, BS2 |
KCCC/NGS Laboratory, |
RCV003316098 | SCV004017465 | benign | Lynch syndrome 8 | 2023-07-07 | criteria provided, single submitter | clinical testing |